Supreme Court allows telehealth access to abortion pill mifepristone nationwide

The US Supreme Court has made a decision regarding the availability of abortion pill mifepristone through telehealth. The court’s ruling allows for the continued use of mifepristone, which is used to induce abortion.

Mifepristone is a medication that can be taken by women in the early stages of pregnancy to terminate their pregnancies. In 2022, the FDA approved mifepristone for emergency use during pregnancy termination.

The Supreme Court’s decision does not change the availability of mifepristone through telehealth, which has been allowed since 2019. This allows women to access the medication remotely, without having to visit a physical clinic or hospital.

The court’s ruling is based on the FDA’s approval of mifepristone for emergency use during pregnancy termination. The decision does not address any specific issues related to the availability of mifepristone through telehealth.

It is worth noting that the Supreme Court’s decision only applies to the specific circumstances of mifepristone and does not affect other abortion-related laws or regulations.

Source: Google News World